For example, a serial analysis of two melanoma-associated markers (tyrosinase and MART-1) was shown to be an independent predictor of disease recurrence for stage IV melanoma patients after surgery and adjuvant therapy [327]. This evidence concerns the gene MLANA and melanoma.